Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects

Gut

Volumn 54, Issue 4, 2005, Pages 515-521

  Knudsen, T T ^b   Thorsen, S ^a   Jensen, S A ^a   Dalhoff, K ^a   Schmidt, L E ^a   Becker, U ^b   Bendtsen, F ^b  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; PARACETAMOL; PROTEIN C; PROTEIN S; PROTHROMBIN; VITAMIN K GROUP; VON WILLEBRAND FACTOR;

ABDOMINAL PAIN; ADULT; ALLERGIC REACTION; ARTICLE; BRONCHOSPASM; DIZZINESS; DRUG EFFECT; DRUG OVERDOSE; ENDOTHELIUM CELL; FEMALE; FLUSHING; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; LIVER INJURY; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RASH; SIDE EFFECT; VOMITING;

ACETYLCYSTEINE; ADULT; ANTIDOTES; ANTIGENS; BLOOD COAGULATION FACTORS; DRUG MONITORING; FACTOR V; FACTOR VIII; FEMALE; HEMOSTASIS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROTEIN C; PROTEIN S; VITAMIN K;

EID: 15444376846     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.043505     Document Type: Article

References (49)

1. Keays R, Harrison PM, Wendon JA, et al. Intravenous acelylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 1991;303:1026-9.
2. Prescott LF, Illingworth RN, Critchley JA, et al. Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning. BMJ 1980;280:46-7.
3. Smilkstein MJ, Bronstein AC, Linden C, et al. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991;20:1058-63.
4. Larsen FS, Kirkegaard P, Rasmussen A, et al. The Danish liver transplantation program and patients with serious acetaminophen intoxication. Transplant Proc 1995;27:3519-20.
5. Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995;109:1907-16.
6. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54.
7. Wolsh TS, Lee A. N-acetylcysteine administration in the critically ill. Intensive Care Med 1999;25:432-4.
8. Heller AR, Groth G, Heller SC, et al. N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients. Crit Care Med 2001;29:272-6.
9. Sklar GE, Subramaniam M. Acetylcysteine treatment for non-acetaminophen-induced acute liver failure. Ann Pharmacother 2004;38:498-500.
10. Moldeus P, Cotgreave IA. N-acetylcysteine. Methods Enzymol 1994;234:482-92.
11. Noszal B, Visky D, Kraszni M. Population, acid-base, and redox properties of N-acetylcysteine conformers. J Med Chem 2000;43:2176-82.
12. Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 1996;16:403-14.
13. Kerr R, Newsome P, Germain L, et al. Effects of acute liver injury on blood coagulation. J Thromb Haemost 2003;1:754-9.
14. Guidelines for the management of acute paracetamol overdosage, 2003. Ref Type: Internet Communication, www.pharmweb.net/pwmirror/pwy/paracetamol/chart. html (accessed 14 January 2005).
15. Harrison PM, O'Grady JG, Keays RT, et al. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ 1990;301:964-6.
16. Dymack IW, Tucker JS, Woolf IL, et al. Coagulation studies as a prognostic index in acute liver failure. Br J Haematol 1975;29:385-95.
17. Jepsen S, Hansen AB. The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects. Scand J Clin Lab Invest 1994;54:543-7.
18. Schmidt LE, Knudsen TT, Dalhoff K, et al. Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury. Lancet 2002;360:1151-2.
19. Dahlback B. Blood coagulation. Lancet 2000;355:1627-32.
20. Burns ER, Goldberg SN, Wenz B. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time. Am J Clin Pathol 1993;100:94-8.
21. Prescott LF, Donovan JW, Jarvie DR, et al. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989;37:501-6.
22. Peyvandi F, Mannucci PM. Rare coagulation disorders. Thromb Haemost 1999;82:1207-14.
23. Bjorkmon S, Berntorp E. Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia. Clin Pharmacokinet 2001;40:815-32.
24. Vukovich T, Auberger K, Weil J, et al. Replacement therapy for a homozygous protein C deficiency-state using a concentrate of human protein C and S. Br J Haematol 1988;70:435-40.
25. Serra J, Sales M, Chitolie A, et al. Multicentre evaluation of IL test trade mark free PS: A fully automated assay to quantify free protein S. Thromb Haemost 2002;88:975-83.
26. Stenflo J. Contributions of Gla and EGF-like domains to the function of vitamin K-dependent coagulation factors. Crit Rev Eukaryot Gene Expr 1999;9:59-88.
27. Kim KY, Rhim T, Choi I, et al. N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity. J Biol Chem 2001;276:40591-8.
28. Garant MJ, Kole S, Maksimova EM, et al. Reversible change in thiol redox status of the insulin receptor alpha-subunit in intact cells. Biochemistry 1999;38:5896-904.
29. Laragione T, Bonetto V, Casoni F, et al. Redox regulation of surface protein thiols: identification of integrin alpha-4 as a molecular target by using redox proteomics. Proc Natl Acad Sci U S A 2003;100:14737-41.
30. Marley R, Patel RP, Orie N, et al. Formation of nanomolar concentrations of S-nitroso-albumin in human plasma by nitric oxide. Free Radic Biol Med 2001;31:688-96.
31. de Wit TR, van Mourik JA. Biosynthesis, processing and secretion of von Willebrand factor: biological implications. Best Pract Res Clin Haematol 2001;14:241-55.
32. Montgomery RR, Gill JC. Interactions between von Willebrand factor and factor VIII: where did they first meet. J Pediatr Hematol Oncol 2000;22:269-75.
33. Barrett KE, Minor JR, Metcalfe DD. Histamine-secretion induced by N-acetyl cysteine. Agents Actions 1985;16:144-6.
34. Hong XJ, Francker A, Diamant B. Effects of N-acetylcysteine on histamine release by sodium fluoride and compound 48/80 from isolated rat mast cells. Int Arch Allergy Appl Immunol 1991;96:338-43.
35. 2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1. J Clin Invest 1987;79:600-8.
36. van der Linden PW, Hack CE, Struyvenberg A, et al. Controlled insect-sting challenge in 55 patients: correlation between activation of plasminogen and the development of anaphylactic shock. Blood 1993;82:1740-8.
37. Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol 2001;115:3-12.
38. Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med 1998;31:710-15.
39. Schmidt LE, Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol 2001;51:87-91.
40. Lynch RM, Robertson R. Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study. Accid Emerg Nurs 2004;12:10-15.
41. Singer AJ, Carracio TR, Mofenson HC. The temporal profile of increased transaminase levels in patients with acetaminophen-induced liver dysfunction. Ann Emerg Med 1995;26:49-53.
42. James LP, Wells E, Beard RH, et al. Predictors of outcome after acetaminophen poisoning in children and adolescents. J Pediatr 2002;140:522-6.
43. Schiodt FV, Ott P, Christensen E, et al. The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage. Clin Pharmacol Ther 2002;71:221-5.
44. Schiodt FV, Ott P, Tygstrup N, et al. Temporal profile of total, bound, and free Gc-globulin after acetaminophen overdose. Liver Transpl 2001;7:732-8.
45. Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminopnen-induced hepatotoxicity. Hepatology 2002;36:659-65.
46. Woo OF, Mueller PD, Olson KR, et al. Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose. Ann Emerg Med 2000;35:363-8.
47. Izumi S, Langley PG, Wendon J, et al. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology 1996;23:1507-11.
48. Pereira LM, Langley PG, Hayllar KM, et al. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut 1992;33:98-102.
49. Olsson B, Johansson M, Gabrielsson J, et al. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol 1988;34:77-82.